NCT03068962

Brief Summary

Dietary nitrate have been shown to have health benefits including lowering blood pressure (Hobbs et al, 2012), improving endothelial function and inhibiting platelet aggregation in healthy humans (Lidder \& Webb, 2013). The main sources of dietary nitrate in the human diet are vegetables such as beetroot. Nitrates are converted to nitrites then nitric oxide (NO), following their reduction by commensal oral bacteria and those residing in the gastrointestinal tract (Hord, Tang, \& Bryan, 2009; Lidder \& Webb, 2013). A recent study has shown following elimination of oral bacteria by the use of a chlorhexidine based antiseptic mouthwash, the conversion of nitrate to nitrite is prevented and this is accompanied by a statistically significant increase in blood pressure in normotensive subjects (Kapil et al., 2013). To date, very few studies have investigated the potential role of these oral bacteria in control of blood pressure and if there are any inter and intra-individual differences in bacterial composition.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2017

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 22, 2017

Completed
7 days until next milestone

Study Start

First participant enrolled

March 1, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 3, 2017

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2017

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2018

Completed
Last Updated

March 3, 2017

Status Verified

February 1, 2017

Enrollment Period

6 months

First QC Date

February 22, 2017

Last Update Submit

February 27, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • oral bacteria sample will be collected to Identification of nitrate reductase-positive bacteria in the oral cavity and capacity to reduce dietary nitrate

    In vitro method will be used to isolate the nitrate reducing bacteria then 16SrDNA sequencing will be used to identify the species of these bacteria.

    1 year

Secondary Outcomes (1)

  • Identify the major sites in the human oral cavity which contain nitrate reducing bacteria.

    1 year

Study Arms (3)

beetroot juice

EXPERIMENTAL

Rinse mouth with low nitrate Buxton mineral water followed by holding 10 ml of beetroot juice for 5 min,

Other: beetroot Juice

low mineral water (Buxton water)

EXPERIMENTAL

Rinse mouth with low nitrate Buxton mineral water followed by holding 10 ml of low nitrate mineral water in the mouth for 5 min or

Other: Buxton water

antiseptic mouthwash then beetroot juice

EXPERIMENTAL

Rinse with antiseptic mouthwash before holding 10 ml of beetroot juice in the mouth for 5 min

Other: beetroot JuiceOther: antiseptic mouthwash then beetroot juice

Interventions

Beetroot Juice

antiseptic mouthwash then beetroot juicebeetroot juice

natural mineral water

low mineral water (Buxton water)

Chlorhexidine glocunate

antiseptic mouthwash then beetroot juice

Eligibility Criteria

Age18 Years - 55 Years
Sexall(Gender-based eligibility)
Gender Eligibility Details10 men and 10 women
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male and female
  • A signed consent form
  • Age 18-55 years
  • Non-smoking, healthy individuals
  • BMI 18.5 - 30 kg/m2

You may not qualify if:

  • Diagnosed with a chronic illness
  • Individuals with food allergies or allergies to medicated mouthwash or ingredients in the oral products
  • Requirements to take long-term medication active on the oral cavity or taken antibiotics within the last 3 months
  • Current diagnosis of dental caries, gingivitis, or periodontal disease or chronic oral complaints or Existing oral pathology (active caries lesions and/or periodontal disease; mucosal lesions; poor occlusion)
  • Current smoker (regular and electronic cigarettes and cigars)
  • Participating in a dietary intervention study.
  • Excessive alcohol consumption (\> 21 units/wk male, \>14 units/wk female)
  • Females who are pregnant or lactating
  • Reduced salivary flow (unstimulated flow less than 0.1 ml/min);
  • less than four natural (enamel) buccal surfaces of upper molars available;
  • presence of fixed or removable oral appliances (e.g., dentures, orthodontic wires)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Food and Nutritional Sciences, University of Reading

Reading, Berkshire, RG6 6AP, United Kingdom

Location

Related Publications (4)

  • Hobbs DA, Kaffa N, George TW, Methven L, Lovegrove JA. Blood pressure-lowering effects of beetroot juice and novel beetroot-enriched bread products in normotensive male subjects. Br J Nutr. 2012 Dec 14;108(11):2066-74. doi: 10.1017/S0007114512000190. Epub 2012 Mar 14.

    PMID: 22414688BACKGROUND
  • Hord NG, Tang Y, Bryan NS. Food sources of nitrates and nitrites: the physiologic context for potential health benefits. Am J Clin Nutr. 2009 Jul;90(1):1-10. doi: 10.3945/ajcn.2008.27131. Epub 2009 May 13.

    PMID: 19439460BACKGROUND
  • Kapil V, Haydar SM, Pearl V, Lundberg JO, Weitzberg E, Ahluwalia A. Physiological role for nitrate-reducing oral bacteria in blood pressure control. Free Radic Biol Med. 2013 Feb;55:93-100. doi: 10.1016/j.freeradbiomed.2012.11.013. Epub 2012 Nov 23.

    PMID: 23183324BACKGROUND
  • Lidder S, Webb AJ. Vascular effects of dietary nitrate (as found in green leafy vegetables and beetroot) via the nitrate-nitrite-nitric oxide pathway. Br J Clin Pharmacol. 2013 Mar;75(3):677-96. doi: 10.1111/j.1365-2125.2012.04420.x.

    PMID: 22882425BACKGROUND

Study Officials

  • Julie A Lovegrove, BSc, PhD

    University of Reading

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Julie A Lovegrove, BSc, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Human Nutrition

Study Record Dates

First Submitted

February 22, 2017

First Posted

March 3, 2017

Study Start

March 1, 2017

Primary Completion

September 1, 2017

Study Completion

March 1, 2018

Last Updated

March 3, 2017

Record last verified: 2017-02

Locations